136
Views
12
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma

, , , , , & show all
Pages 2215-2221 | Received 23 Mar 2010, Accepted 21 Sep 2010, Published online: 26 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Albert Altés, Laia Paré, Albert Esquirol, Blanca Xicoy, Elena Rámila, Laura Vicente, Rosario López, Jaume Orriols, Ferran Vall-llovera, Blanca Sánchez-González, Elisabeth del Río, Anna Sureda, David Páez & Montserrat Baiget. (2013) Pharmacogenetic analysis in the treatment of Hodgkin lymphoma. Leukemia & Lymphoma 54:8, pages 1706-1712.
Read now
Olav E. Yri, Per O. Ekstrøm, Vera Hilden, Gustav Gaudernack, Knut Liestøl, Erlend B. Smeland & Harald Holte. (2012) Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma. Leukemia & Lymphoma 53:10, pages 1934-1944.
Read now

Articles from other publishers (10)

J. R. Vido-Marques, S. C. Reis-Alves, S. T. O. Saad, K. Metze & I. Lorand-Metze. (2020) A simple score derived from bone marrow immunophenotyping is important for prognostic evaluation in myelodysplastic syndromes. Scientific Reports 10:1.
Crossref
Bruna de A. Murbach, Marcia T. Delamain, Vanessa Daniel, Carmino A. Souza, Carmen S. P. Lima & Gustavo J. Lourenço. (2018) Association between polymorphisms in angiogenesis‐related genes and the prognosis of classical Hodgkin lymphoma. British Journal of Haematology 185:2, pages 366-370.
Crossref
L Lopes-Aguiar, M T Delamain, A B C Brito, G J Lourenço, E F D Costa, G B Oliveira, J Vassallo, C A De Souza & C S P Lima. (2017) VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens. Blood Cancer Journal 7:6, pages e580-e580.
Crossref
Xiangzhen Kong, Zihao Li & Xian Li. (2016) GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis. Cancer Chemotherapy and Pharmacology 78:6, pages 1163-1173.
Crossref
Monica Napoleão Fortes Rego, Konradin Metze & Irene Lorand-Metze. (2015) Low educational level but not low income impairs the achievement of cytogenetic remission in chronic myeloid leukemia patients treated with imatinib in Brazil. Clinics 70:5, pages 322-325.
Crossref
Jian‑Yong Wang, Xiu‑Hong Jia, Hai‑Yan Xing, You‑Jie Li, Wen‑Wen Fan, Na Li & Shu‑Yang Xie. (2015) Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia. Molecular Medicine Reports.
Crossref
Suiellen C. Reis-Alves, Fab?ola Traina, Guilherme Harada, Paula M. Campos, Sara T. O. Saad, Konradin Metze & Irene Lorand-Metze. (2013) Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores. PLoS ONE 8:12, pages e81048.
Crossref
Yun-Lu Bai, Bing Zhou, Xiao-Yue Jing, Bin Zhang, Xiao-Qing Huo, Chao Ma & Jian-Miao He. (2012) Predictive Role of GSTs on the Prognosis of Breast Cancer Patients with Neoadjuvant Chemotherapy. Asian Pacific Journal of Cancer Prevention 13:10, pages 5019-5022.
Crossref
Caroline F. Thorn, Yuan Ji, Richard M. Weinshilboum, Russ B. Altman & Teri E. Klein. (2012) PharmGKB summary. Pharmacogenetics and Genomics 22:8, pages 646-651.
Crossref
Enrico Derenzini & Anas Younes. (2011) Predicting treatment outcome in classical Hodgkin lymphoma: genomic advances. Genome Medicine 3:4, pages 26.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.